Research Tracker›Biomarker Atlas›Long COVID›Low naive T cells / High effector memory

Low naive T cells / High effector memory in Long COVID

In Long COVID (PASC, Post-Acute Sequelae of COVID-19), the direction of change for Low naive T cells / High effector memory, also described as T cell subset shift, is inconsistent across studies that used healthy controls as the reference group. Symptom domains tied to this marker in the source include immune repertoire alteration. The evidence summarised here comes from Baalbaki et al. 2025 and reflects averages across cohorts rather than any single patient's result.

↕ InconsistentImmune

Summary

Direction in Long COVID↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryImmune
Also described asT cell subset shift
Compared againstHC (healthy controls)
Associated symptomsImmune repertoire alteration
Test typeBlood test (serum / plasma / whole blood)
SourceBaalbaki et al. 2025 — doi:10.1111/all.16526
Condition atlasLong COVID Biomarker Atlas

Related Immune markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is Low naive T cells / High effector memory high or low in Long COVID?

Mixed. Some studies report higher and others lower Low naive T cells / High effector memory in Long COVID compared with healthy controls, so no single direction is established. Source: Baalbaki et al. 2025.

What symptoms is Low naive T cells / High effector memory associated with in Long COVID?

The cited literature associates this marker with Immune repertoire alteration. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Low naive T cells / High effector memory?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Low naive T cells / High effector memory result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. Low naive T cells / High effector memory findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Low naive T cells / High effector memory in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/low-naive-t-cells-high-effector-memory.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.